Immunopeptidomic MHC-I profiling and immunogenicity testing identifies Tcj2 as a new Chagas disease mRNA vaccine candidate.

Autor: Versteeg, Leroy1,2 (AUTHOR) Leroy.Versteeg@bcm.edu, Adhikari, Rakesh1 (AUTHOR), Robinson, Gonteria1 (AUTHOR), Lee, Jungsoon1 (AUTHOR), Wei, Junfei1 (AUTHOR), Islam, Nelufa1 (AUTHOR), Keegan, Brian1 (AUTHOR), Russell, William K.3 (AUTHOR), Poveda, Cristina1 (AUTHOR), Villar, Maria Jose1 (AUTHOR), Jones, Kathryn1,4 (AUTHOR), Bottazzi, Maria Elena1,4,5 (AUTHOR), Hotez, Peter1,4,5 (AUTHOR), Tijhaar, Edwin2 (AUTHOR) Edwin.Tijhaar@wur.nl, Pollet, Jeroen1 (AUTHOR) Jeroen.Pollet@bcm.edu
Zdroj: PLoS Pathogens. 12/18/2024, Vol. 20 Issue 12, p1-35. 35p.
Databáze: Academic Search Ultimate
Nepřihlášeným uživatelům se plný text nezobrazuje